195 related articles for article (PubMed ID: 15013219)
1. RET and neuroendocrine tumors.
Ichihara M; Murakumo Y; Takahashi M
Cancer Lett; 2004 Feb; 204(2):197-211. PubMed ID: 15013219
[TBL] [Abstract][Full Text] [Related]
2. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
[TBL] [Abstract][Full Text] [Related]
3. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
Kurokawa K; Iwashita T; Murakami H; Hayashi H; Kawai K; Takahashi M
Oncogene; 2001 Apr; 20(16):1929-38. PubMed ID: 11360177
[TBL] [Abstract][Full Text] [Related]
4. The GDNF/RET signaling pathway and human diseases.
Takahashi M
Cytokine Growth Factor Rev; 2001 Dec; 12(4):361-73. PubMed ID: 11544105
[TBL] [Abstract][Full Text] [Related]
5. Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.
Murakami H; Iwashita T; Asai N; Shimono Y; Iwata Y; Kawai K; Takahashi M
Biochem Biophys Res Commun; 1999 Aug; 262(1):68-75. PubMed ID: 10448070
[TBL] [Abstract][Full Text] [Related]
6. The RET receptor tyrosine kinase: activation, signalling and significance in neural development and disease.
Mason I
Pharm Acta Helv; 2000 Mar; 74(2-3):261-4. PubMed ID: 10812967
[TBL] [Abstract][Full Text] [Related]
7. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations.
Ohiwa M; Murakami H; Iwashita T; Asai N; Iwata Y; Imai T; Funahashi H; Takagi H; Takahashi M
Biochem Biophys Res Commun; 1997 Aug; 237(3):747-51. PubMed ID: 9299438
[TBL] [Abstract][Full Text] [Related]
9. Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons.
Creedon DJ; Tansey MG; Baloh RH; Osborne PA; Lampe PA; Fahrner TJ; Heuckeroth RO; Milbrandt J; Johnson EM
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):7018-23. PubMed ID: 9192684
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.
De Vita G; Melillo RM; Carlomagno F; Visconti R; Castellone MD; Bellacosa A; Billaud M; Fusco A; Tsichlis PN; Santoro M
Cancer Res; 2000 Jul; 60(14):3727-31. PubMed ID: 10919641
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
Marsh DJ; Zheng Z; Arnold A; Andrew SD; Learoyd D; Frilling A; Komminoth P; Neumann HP; Ponder BA; Rollins BJ; Shapiro GI; Robinson BG; Mulligan LM; Eng C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3025-8. PubMed ID: 9284737
[TBL] [Abstract][Full Text] [Related]
12. Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation.
Hayashi Y; Iwashita T; Murakamai H; Kato Y; Kawai K; Kurokawa K; Tohnai I; Ueda M; Takahashi M
Biochem Biophys Res Commun; 2001 Mar; 281(3):682-9. PubMed ID: 11237712
[TBL] [Abstract][Full Text] [Related]
13. Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
Salvatore D; Melillo RM; Monaco C; Visconti R; Fenzi G; Vecchio G; Fusco A; Santoro M
Cancer Res; 2001 Feb; 61(4):1426-31. PubMed ID: 11245446
[TBL] [Abstract][Full Text] [Related]
14. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.
Mograbi B; Bocciardi R; Bourget I; Juhel T; Farahi-Far D; Romeo G; Ceccherini I; Rossi B
Mol Cell Biol; 2001 Oct; 21(20):6719-30. PubMed ID: 11564857
[TBL] [Abstract][Full Text] [Related]
15. Grb2 binding to the different isoforms of Ret tyrosine kinase.
Alberti L; Borrello MG; Ghizzoni S; Torriti F; Rizzetti MG; Pierotti MA
Oncogene; 1998 Sep; 17(9):1079-87. PubMed ID: 9764818
[TBL] [Abstract][Full Text] [Related]
16. Role of Dok1 in cell signaling mediated by RET tyrosine kinase.
Murakami H; Yamamura Y; Shimono Y; Kawai K; Kurokawa K; Takahashi M
J Biol Chem; 2002 Sep; 277(36):32781-90. PubMed ID: 12087092
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction by the receptor tyrosine kinase Ret.
van Weering DH; Bos JL
Recent Results Cancer Res; 1998; 154():271-81. PubMed ID: 10027007
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation.
van Weering DH; Bos JL
J Biol Chem; 1997 Jan; 272(1):249-54. PubMed ID: 8995255
[TBL] [Abstract][Full Text] [Related]
19. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.
Melillo RM; Santoro M; Ong SH; Billaud M; Fusco A; Hadari YR; Schlessinger J; Lax I
Mol Cell Biol; 2001 Jul; 21(13):4177-87. PubMed ID: 11390647
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.
Maeda K; Murakami H; Yoshida R; Ichihara M; Abe A; Hirai M; Murohara T; Takahashi M
Biochem Biophys Res Commun; 2004 Oct; 323(1):345-54. PubMed ID: 15351743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]